A start-up should always have a “plan B” to provide a critical safety net. A considerable and expensive amount of redundant lab equipment can sit idle if that pivot arises and prompts a significant ...

As the biotech sector continues to evolve, breakthroughs in antibody technology are reshaping the landscape of cancer ...

Discover the captivating world of Cyclist Lift in our latest video! Join us as we explore this innovative and dynamic ...

Detailed price information for Bionxt Solutions Inc. (BNXT-CN) from The Globe and Mail including charting and trades.

The Science Behind Mama's Microbe Madness Let's get real about what's actually happening inside those jars lining your ...

Aussie investors are blessed with a wealth of high quality stocks operating in a variety of healthcare sectors. Healthcare ...

Sara Ingle knit her first sweater in 2018. Five years later, she became the owner of Boston Fiber Company, a knitting supplies store in the South End that prides itself on cultivating an inclusive ...

UD chemical engineer wins the AIChE Langer Prize for efforts to harness biology to manage plastic waste sustainably ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend ...

Diana Crandall is a deputy editor of automation at Forbes Marketplace. With a master's degree in journalism from the University of Southern California and a background in marketing, she combines ...